A House of Representatives Subcommittee held a hearing yesterday on "Intellectual Property and Strategic Competition with China," with members of the Subcommittee and expert witnesses discussing a number of issues related to Chinese intellectual property protection, including the patent system and innovation in China.

Earlier this week, the Office of the U.S. Trade Representative issued its 2022 Review of Notorious Markets for Counterfeiting and Piracy (Notorious Markets List, or NML), which "highlights prominent and illustrative examples of online and physical markets that reportedly engage in, facilitate, turn a blind eye to, or benefit

At Friday's meeting of the WTO's Dispute Settlement Body (DSB), panels were established in two complaints brought against China by the EU, related to allegations about China's trade restrictions imposed on Lithuania and about restrictions on EU companies going to a foreign court to protect and use their patents.

After the failure by Pfizer and the Chinese government to reach an agreement on including COVID medicine Paxlovid in the state health insurance plan, there are some discussions in China on whether compulsory licensing is justified as cases are surging in the nation.

Earlier this year, the EU requested consultations with China at the WTO on two separate matters, related to allegations about China's trade restrictions imposed on Lithuania and about restrictions on EU companies going to a foreign court to protect and use their patents. Today, the EU announced that consultations had

In the annual report of the U.S.-China Economic and Security Review Commission issued yesterday, the Commission assessed and made recommendations on the issue of "anti-suit injunctions" issued by Chinese courts to enforce patents.

China's National Intellectual Property Administration (NIPA) updated the lists of demonstration and pilot cities for intellectual property rights (IPR) protection, part of its effort to enhance IPR protection and promote IP.